• Comments to the Food and Drug Administration on the Draft Guidance for Industry, Clinical Laboratories, and FDA Staff on In Vitro Diagnostic Multivariate Index Assays – October 5, 2007
• Letter to Senate on National Institutes of Health (NIH) Public Access Policy – September 17, 2007
• Letter to House and Senate Appropriations Committee Members on National Institutes of Health (NIH) Public Access Policy – June 19, 2007
• Comments to the Secretary’s Advisory Committee on Genetics, Health, and Society on Pharmacogenomics – June 1, 2007
• Letter to the Chairs of the Senate and House Appropriations Subcommittees on Labor-HHS – May 21, 2007
• Comments to the Food and Drug Administration (FDA) in Response to Their Draft Guidance on Analyte Specific Reagents (ASRs) – February 22, 2007
• Comments to the Food and Drug Administration (FDA) in Response to Their Draft Guidance on In Vitro Diagnostic Multivariate Index Assays (IVDMIAs) – February 22, 2007
• Comments to the National Institutes of Health (NIH) in Response to Their Request for Information on Data-Sharing Policy in Relation to Genome-Wide Association Studies (GWAS) – November 30, 2006
• Comments to the National Institutes of Health (NIH) in Response to Their Request for Information on the Roadmap Initiative – November 17, 2006
• Letter to the Centers for Medicare and Medicaid Services (CMS) Requesting a Genetics Specialty Under the Clinical Laboratory Improvement Amendments (CLIA) – October 11, 2006
• Citizen’s petition to the Centers for Medicare and Medicaid Services (CMS) Requesting a Genetics Specialty Under the Clinical Laboratory Improvement Amendments (CLIA) – September 26, 2006
• Press Conference Statement on the Citizen’s Petition to the Centers for Medicare and Medicaid Services (CMS) Requesting a Genetics Specialty Under the Clinical Laboratory Improvement Amendments (CLIA) – September 26, 2006
• Letter to the Centers for Medicare and Medicaid Services (CMS) Requesting a Genetics Specialty Under the Clinical Laboratory Improvement Amendments (CLIA) – June 6, 2006
• Letter to the Centers for Medicare and Medicaid Services (CMS) Requesting a Genetics Specialty Under the Clinical Laboratory Improvement Amendments (CLIA) – February 28, 2006
• Comments to the Food and Drug Administration (FDA) on Direct-to-Consumer Marketing of Genetic Tests - November 2, 2005
• Comments to the Secretary’s Advisory Committee on Genetics, Health, and Society – May 6, 2005
• Comments to Secretary’s Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children – May 5, 2005
• Comments on Passage of the Genetic Information Nondiscrimination Act (S. 306) in the Senate – February 17, 2005
• Testimony to Secretary’s Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children – September 23, 2004
• Comments to the Secretary’s Advisory Committee on Genetics, Health, and Society – March 1, 2004
• Testimony Before the House Committee on Energy and Commerce Subcommittee on Oversight and Investigations Hearing on Human Cloning – March 28, 2001

View current policy statements.